Novo Nordisk Foundation Initiative for Vaccines and Immunity

The future of research in vaccines and immunity

The aim of the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) is to revolutionize and accelerate vaccine development in Denmark by bridging the gap between academic research and industry innovation.

COLLABORATION

About the initiative (NIVI)

Read about the organisational structure of NIVI

Research

Scientific research fields

The scientific program at the NCVI is structured as an integrated research effort that connects four major thematic areas: Airway Immunity, Vaccine Platforms, Airway Delivery and Respiratory Pathogens.

Research

Research at the center

Browse the research of NIVI at UCPH

Collaboration

About the center - NCVI

Read about the organisational structure of the centre

News

Vaccines

2024.03.14

NIVI welcomes Executive Director and CEO to lead novel vaccine research and development initiative

Dr. Nicholas Jackson will be the Executive Director and CEO of the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), a partnership between the University of Copenhagen and the Novo Nordisk Foundation, announced in December 2023. He takes on the role from May 1, 2024, marking a strategic milestone in NIVI's pursuit of global health innovation in vaccines.

About the initiative - NIVI

Research

Learn more about The Novo Nordisk Foundation Initiative for Vaccines and Immunity

Our Vision is to prevent airborne epidemics and limit the spread of anti-microbial resistance through the development of novel vaccines.

Discover a world of vaccine innovation at NIVI

The future of research in vaccines and immunity

About the initiative (NIVI)

Scientific research fields

Research at the center

About the center - NCVI

News

NIVI welcomes Executive Director and CEO to lead novel vaccine research and development initiative

About the initiative - NIVI

Learn more about The Novo Nordisk Foundation Initiative for Vaccines and Immunity